Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

King Pharmaceuticals: Financial Gauge Analysis for the March 2010 Quarter
Seeking Alpha
Monday, May 24, 2010 - 7:58am
tags:
earnings, King, financial
Zacks Analyst Blog Highlights: Amgen Inc., Novartis, Merck, GlaxoSmithKline and Eli Lilly
Yahoo/Zacks.com
Monday, May 24, 2010 - 7:56am
tags:
Amgen, Merck, Eli Lilly, GSK, Novartis
Clinical Data gets approval of depression drug
Yahoo/AP
Monday, May 24, 2010 - 7:54am
tags:
Clinical Data, FDA, antidepressants, Vilazodone, Merck Serono
Pfizer, Washington University Collaborate to Find New Uses for Old Drugs
Seeking Alpha
Monday, May 24, 2010 - 7:53am
tags:
Pfizer, partnerships
8th ChinaBio® Investor Forum Selects Three “Most Promising” Companies
Emerginvest
Sunday, May 23, 2010 - 12:19pm
tags:
Advanced Cell Diagnostics, Reach Surgical, Magpie Pharmaceuticals, China, China Biotech
Amgen Highlights Key Clinical Data to Be Presented at American Society of Clinical Oncology Annual Meeting
PR-USA
Sunday, May 23, 2010 - 12:07pm
tags:
Amgen, denosumab, zoledronic acid, Bone metastases, prostate cancer
Boehringer Ingelheim to Present New Data Regarding Its Investigational Compound BIBW 2992 in Head and Neck Cancer
PR-USA
Sunday, May 23, 2010 - 12:06pm
tags:
Boehringer Ingelheim, head and neck cancer, BIBW 2992
Lilly Presents New Data in Advanced Melanoma
PR-USA
Sunday, May 23, 2010 - 12:04pm
tags:
Eli Lilly, melanoma, tasisulam
Biotech co Aposense raises $3m ahead of IPO
Globes, Israel
Sunday, May 23, 2010 - 12:02pm
tags:
Aposense, biotech
Abbott, Varian Healthcare and Novartis to Discuss Impact of Healthcare Reform on the Supply Chain at Elite Industry Supply Chain Summit
Earthtimes
Sunday, May 23, 2010 - 11:59am
tags:
Abbott Laboratories, Varian Medical, Novartis, health care reform
Out-of-Pocket Costs Put Arthritis Drugs Out Of Reach For Some
Medical News Today
Sunday, May 23, 2010 - 11:57am
tags:
arthritis, rheumatoid arthritis
Pfizer loss signals opportunity
Irish Independent, Ireland
Sunday, May 23, 2010 - 11:55am
tags:
Pfizer
China Biotech Week in Review: Deals Abound
Seeking Alpha
Sunday, May 23, 2010 - 11:32am
tags:
China, China Biotech, biotech, Sichuan Kelun Pharmaceutical, GanLee Pharmaceutical, OriGene Technologies, BGI, Tianjin Tasly Pharmaceutical Co, Simcere, GeneNews Limited, GSK
Healthcare: Ailing Sector Laid Low by Big Pharma
Seeking Alpha
Sunday, May 23, 2010 - 11:30am
tags:
Big Pharma
Astellas Seals the Deal With OSI After Rocky Courtship
Seeking Alpha
Sunday, May 23, 2010 - 11:27am
tags:
Astellas, OSI Pharmaceuticals, M&A
Global Drug MNCs Eye Indian Pharma Majors For Probable Acquisition
Economy News, India
Saturday, May 22, 2010 - 10:39am
tags:
M&A, India
AnaSpec Introduces Anti-5-Methylcytidine Monoclonal Antibody
Earthtimes
Saturday, May 22, 2010 - 10:22am
tags:
Anaspec, Eurogentec, monoclonal antibodies, anti-5-methylcytidine
Moody's lowers Eli Lilly outlook to 'negative'
BusinessWeek
Saturday, May 22, 2010 - 10:19am
tags:
Eli Lilly, investors
Noteworthy Trading Activity for Par Pharmaceutical Companies Inc.
Market Intellisearch
Saturday, May 22, 2010 - 10:14am
tags:
Par Pharmaceutical, investors
Celldex shares fall following study update
Yahoo/AP
Saturday, May 22, 2010 - 10:13am
tags:
Celldex, brain cancer, CDX-110

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.